Clinical features, diagnostic tools, and treatment regimens for visceral leishmaniasis in Bulgaria

Pathogens and Global Health

Volumn 107, Issue 5, 2013, Pages 260-266

  Harizanov, Rumen N ^a   Kaftandjiev, Iskren T ^a   Jordanova, Diana P ^a   Marinova, Irina B ^a   Tsvetkova, Nina D ^a  

^a NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

Clinical symptoms; Diagnostic techniques; Therapeutic regimens; Visceral leishmaniasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; AMPHOTERICIN B LIPID COMPLEX; ASPARTATE AMINOTRANSFERASE; HEMOGLOBIN; MEGLUMINE ANTIMONATE; MILTEFOSINE; PENTAMIDINE;

ADULT; AGED; AMASTIGOTE; ANEMIA; ARTICLE; BLEEDING TENDENCY; BULGARIA; CLINICAL EXAMINATION; FEMALE; HEPATOMEGALY; HEPATORENAL SYNDROME; HUMAN; HUMAN TISSUE; LEUKOCYTE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MYELOFIBROSIS; PARASITOLOGY; PARASITOLOGY ELISA KIT; POLYMERASE CHAIN REACTION; SEPSIS; SEROLOGY; SUDDEN CARDIAC DEATH; THROMBOCYTE; THYROTOXICOSIS; VISCERAL LEISHMANIASIS;

EID: 84881177289     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773213Y.0000000101     Document Type: Article

References (23)

1. Faucher B, Gaudart J, Faraut F, Pomares C, Mary C, Marty P, et al. Heterogeneity of environments associated with transmission of visceral leishmaniasis in South-Eastern France and implication for control strategies. PLoS Negl Trop Dis. 2012;6(8):e1765
2. European Parliament and Council Directive 2003/99/EC. Nov 17, 2003. On the Monitoring of Zoonoses and Zoonotic agents (Amends Council Decision 90/424/EEC and repeals Council Directive 92/117/EEC. OJ L 325, 12.12.2003: 31.
3. WHO. Control of leishmaniasis: report of a Meeting of the WHO Expert Committee on the Control of Leishmaniasis. Geneva, 22-26 March. WHO Technical Report no. 949, 2010. p. 202.
4. Vasileva K. Population and social conditions. Eurostat. 2011;34:1-7.
5. Pavli A, Maltezou HC. Leishmaniasis, an emerging infection in travelers. Int J Infect Dis. 2010;14:e1032-9.
6. Malik AN, John L, Bruceson AD, Lockwood DN. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004. Emerg Infect Dis. 2006;12:1257-9, doi: 10.3201/eid1208.050486
7. Gruev T. Contributions to the study of leishmaniasis (kalaazar) in the countryside. Medical Records. 1949;8:845-55 [in Bulgarian].
8. Bratanov B. First contributions to autochthonous childhood visceral leishmaniasis in Bulgaria. Scientific Works of Internal and Pediatric Medicine. ISUL, 1952:113-58 [in Bulgarian].
9. Andreev I, Angelov A, Karapanchev B. Observation of cases of kala azar in childhood. Ped Obst Gyn. 1958;2:38-46 [in Bulgarian].
10. Filipov G, Harizanov R, Jordanova D, Vuchev D, Kurdova R, Dimitrov H. Current state of visceral leishmaniasis in Bulgaria. Infectology. 2003;4:29-31 [in Bulgarian].
11. Vutova K. Visceral leishmaniasis: clinical and laboratory features and treatment. Med Rev. 2007;3:26-31 [in Bulgarian].
12. Harizanov R. Visceral leishmaniasis. In: Kurdova R (eds.), Parasitic zoonosis in humans. NCIPD; 2008. p. 145-75 [in Bulgarian].
13. Boeva-Bangiozova V, Yancheva N. Visceral leishmaniasis. Physician Pract. 2009;11(1):21-7 [in Bulgarian].
14. Filipov G, Jordanova D, Rainova I. Studies on the diagnostic capabilities of the immunofluorescence reaction in visceral leishmaniasis. Infectology. 1999;2:39-41 [in Bulgarian].
15. Piarroux R, Fontes M, Perasso R, Gambarelli F, Joblet C, Dumon H, et al. Phylogenetic relationships between Old World Leishmania strains revealed by analysis of a repetitive DNA sequence. Mol Biochem Parasitol. 1995;73:249-52.
16. Ranchov G. Biostatistics. Sofia, Bulgaria: GorexPress 2004. p.182 [in Bulgarian].
17. WHO. Control of the leishmaniasis. Technical Report Series 793. 1990. p. 158.
18. Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol. 2002;9(5):951-8, doi: 10.1128/ CDLI.9.5.951-958.2002
19. Cruz I, Chicharro C, Nieto J, Bailo D, Canavate C, Figueras M-C, et al. Comparison of new diagnostic tools for management of paediatric Mediterranean visceral leishmaniasis. J Clin Microbiol. 2006;44(7):2343-7, doi: 10.1128/JCM.02297-05
20. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2:494-501.
21. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5:7-16, doi:10.1038/nrmicro1748
22. Gradoni L, Gramiccia M, Scalone A. Visceral leishmaniasis treatment, Italy. Emerg Infect Dis. 2003;9(12):1617-20.
23. Monzote L. Current treatment of leishmaniasis: a review. Open Antimicrob Agents J. 2009;1:9-19.